Status:
RECRUITING
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Lead Sponsor:
Center for International Blood and Marrow Transplant Research
Collaborating Sponsors:
National Marrow Donor Program
Conditions:
Hematologic Malignancies
Inherited Disorders of Metabolism
Eligibility:
All Genders
Brief Summary
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
Detailed Description
Principal Investigators: The principal investigators (PIs) will be transplant physicians at all participating U.S. transplant centers. Study Design: This study is an access and distribution protoco...
Eligibility Criteria
Inclusion Criteria:
- Disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment
- Signed informed consent (and signed assent, if applicable) obtained prior to study enrollment
- Pediatric and adult patients of any age
Exclusion Criteria:
- Patients who are receiving only licensed CBUs
- Cord blood transplant recipients at international transplant centers
- Patients who are enrolled on another IND protocol to access the unlicensed CBU(s)
- Patients whose selected unlicensed CBU(s) will be more than minimally manipulated
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2041
Estimated Enrollment :
99999 Patients enrolled
Trial Details
Trial ID
NCT01351545
Start Date
October 1 2011
End Date
October 1 2041
Last Update
April 13 2026
Active Locations (142)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233
2
Banner MD Anderson Cancer Center
Gilbert, Arizona, United States, 85234
3
Phoenix Children's Hospital
Phoenix, Arizona, United States, 85016
4
Mayo Clinic Arizona (adults)
Phoenix, Arizona, United States, 85054